Hamilton Medical AG, headquartered in Switzerland (CH), is a leading innovator in the medical technology industry, specialising in advanced ventilation solutions. Founded in 1983, the company has established a strong presence in Europe, North America, and Asia, focusing on critical care and anaesthesia. Hamilton Medical is renowned for its cutting-edge ventilators and intelligent ventilation software, which enhance patient outcomes through precision and adaptability. Their flagship products, such as the HAMILTON-G5 and HAMILTON-C6, are distinguished by their unique features, including adaptive support modes and user-friendly interfaces. With a commitment to research and development, Hamilton Medical AG has achieved significant milestones, positioning itself as a trusted partner in hospitals worldwide. The company’s dedication to innovation and quality has earned it a prominent market position, making it a preferred choice among healthcare professionals in critical care settings.
How does Hamilton Medical AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Hamilton Medical AG's score of 43 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Hamilton Medical AG reported total greenhouse gas emissions of approximately 275,928,000 kg CO2e, comprising 500,000 kg CO2e from Scope 1, 1,500,000 kg CO2e from Scope 2, and about 273,928,000 kg CO2e from Scope 3 emissions. The company has set ambitious reduction targets in line with the Science Based Targets initiative (SBTi), aiming for a 42% reduction in absolute Scope 1 and 2 emissions by 2030, based on a 2020 baseline. Additionally, Hamilton Medical AG is committed to reducing Scope 3 emissions by 52% per CHF value added within the same timeframe. The latest emissions data for 2024 indicates a total of approximately 151,254,000 kg CO2e, although specific breakdowns by scope are not provided for this year. The company’s commitment to sustainability is further underscored by its alignment with the SBTi, which ensures that its targets are consistent with the reductions necessary to limit global warming to 1.5°C. Hamilton Medical AG's climate commitments reflect a proactive approach to addressing climate change, with a clear focus on significant emissions reductions across all scopes. The data reported is cascaded from the parent organization, Hamilton Medical AG, ensuring a comprehensive view of its environmental impact and commitments.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 750,000 | 000,000 | - |
| Scope 2 | 1,750,000 | 0,000,000 | - |
| Scope 3 | 273,928,000 | 000,000,000 | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Hamilton Medical AG has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Common questions about Hamilton Medical AG's sustainability data and climate commitments
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.